MLSS

Vorhandelsmarkt: .34

Milestone Scientific Inc. (MLSS)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Milestone Scientific Inc. Stock (MLSS) Company Profile

Milestone Scientific Inc.

Healthcare (1107)

973-535-2717

220 South Orange Avenue, Livingston, NJ

@M_Scientific

Nächster Verdiensttermin

Neueste SEC-Einreichungen

MLSS's Discussions on Twitter

Compare MLSS vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MLSS Milestone Scientific Inc.	0.34	29.77M	8.90M	-4.57M	-1.84M	-0.0556
ISRG Intuitive Surgical Inc	417.07	147.53B	10.58B	3.00B	2.83B	8.2437
BDX Becton Dickinson Co	145.16	40.10B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	65.84	32.33B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	37.09	31.57B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	193.94	27.96B	5.54B	1.52B	1.74B	10.37

Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-09-16	Eingeleitet	Northland Capital	Market Perform
2018-11-16	Bestätigt	Maxim Group	Buy
2016-12-23	Bestätigt	Maxim Group	Buy
2015-12-11	Eingeleitet	Maxim Group	Buy

Milestone Scientific Inc. Aktie (MLSS) Neueste Nachrichten

Finanzdaten der Milestone Scientific Inc.-Aktie (MLSS)

Milestone Scientific Inc. (MLSS)

Milestone Scientific Inc. Stock (MLSS) Company Profile

Compare MLSS vs ISRG, BDX, ALC, MDLN, RMD

Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades

Milestone Scientific Inc. Aktie (MLSS) Neueste Nachrichten

MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss and Positive SurpriseBalance Sheet Strength - newsline.com

Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower-than-Expected Loss Per ShareBook Value Growth - newsline.com

SpaceX Shares Surge 11% in Nasdaq Debut After Landmark $75 Billion IPOPreliminary Results - newsline.com

NASA’s experimental quiet supersonic plane passes another critical milestone - Scientific American

Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherROA Comparison - newsline.com

Milestone Scientific (MLSS) asks shareholders to expand share authorization and equity plan - Stock Titan

[EFFECT] MILESTONE SCIENTIFIC INC. SEC Filing - Stock Titan

World Dental Anesthesia Delivery SystemsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox

Milestone Scientific (MLSS) registers 15.9M shares; warrants exercisable at $0.3375 - Stock Titan

Milestone Scientific (MLSS) asks shareholders to increase authorized shares and equity plan - Stock Titan

DiagnosTear Achieves Major Scientific Milestone with Publication of TeaRx(TM) Clinical Study in Current Eye Research Journal - TMX Newsfile

Milestone Scientific approves stock option repricing and new performance-based awards - Investing.com

MLSS: Selling Stockholder to Offer Nearly 8 Million Shares - GuruFocus

Milestone Scientific (NYSE American: MLSS) registers 15.9M shares from April 2026 placement - Stock Titan

Amazon Stock Could Reach $300 This Year: Key Drivers from Yahoo Finance AnalysisConsensus Beat Rate - The Legal Advocate

Japan hits 6G key milestone with high-frequency speeds topping 100 Gbps - Live Science

Milestone Scientific (MLSS) Rallies 3.9% as Shares Approach Key Resistance at $0.42Calendar Spread Trade - newsline.com

Milestone Scientific’s CompuFlo® Technology Sees Increased Physician Adoption Due to Real-Time Pressure Sensing - geneonline.com

Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures - The Manila Times

Milestone Scientific Inc. Reports Increased Adoption of CompuFlo® Epidural System Following Positive Research Findings from University of Texas Medical Branch - Quiver Quantitative

Epidural-guiding device cuts SCS complications by 91% in UTMB study - Stock Titan

Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer Treatments - Business Wire

Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower Loss Beats Estimates as Stock Edges LowerOpen Signal Network - Newser

MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss Per ShareDividend Growth Analysis - newsline.com

MLSS Q1 2026 Earnings: Narrower-Than-Expected Loss as Commercial Efforts ContinueEarnings Revision Downgrade - The Legal Advocate

NTHI Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Focuses on Pipeline Development - The Legal Advocate

Benchmark reiterates Milestone Scientific stock rating on revenue guidance By Investing.com - Investing.com Nigeria

Benchmark reiterates Milestone Scientific stock rating on revenue guidance - Investing.com

Milestone Scientific (MLSS) price target decreased by 50.00% to 1.02 - MSN

Milestone Scientific (MLSS) Up +1.01% — Is There More Room to Run? 2026-05-18Volume Climax - The Legal Advocate

Milestone Scientific, Inc. Common Stock (NY: MLSS - FinancialContent

Thermo Fisher Deepens Oncology Role With Ibtrozi Manufacturing Milestone - Yahoo Finance

Maxim Group Maintains Milestone Scientific(MLSS.US) With Buy Rating, Maintains Target Price $1 - Moomoo

Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global Challenges - GuruFocus

Milestone Scientific Earnings Call Signals Cautious Upswing - TipRanks

Milestone Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

Earnings Call Summary | Milestone Scientific(MLSS.US) Q1 2026 Earnings Conference - Moomoo

MLSS Projects Strong Revenue Growth Through 2026 - GuruFocus

Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations By Investing.com - Investing.com Nigeria

Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations - Investing.com

Milestone Scientific (MLSS) Reports Q1 Revenue Challenges with P - GuruFocus

Full Transcript: Milestone Scientific Q1 2026 Earnings Call - Benzinga

Milestone Scientific stock surges 9% on narrower loss By Investing.com - Investing.com South Africa

Milestone Scientific Q1 revenue steady, operating loss narrows - TradingView

Milestone Scientific stock surges 9% on narrower loss - Investing.com UK

Milestone Scientific Reports Financial Results for First Quarter 2026 - marketscreener.com

Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com

Milestone Scientific earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada

Milestone Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

Milestone Scientific (MLSS) trims Q1 2026 loss but flags going concern and NYSE listing risks - Stock Titan

Earnings call transcript: Core Scientific Q1 2026 reveals mixed performance - Investing.com

Finanzdaten der Milestone Scientific Inc.-Aktie (MLSS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie MLSS